TD-198946

TargetMol
Product Code: TAR-T4193
Supplier: TargetMol
CodeSizePrice
TAR-T4193-1mg1mg£163.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-2mg2mg£198.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-5mg5mg£269.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-1mL1 mL * 10 mM (in DMSO)£281.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-10mg10mg£389.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-25mg25mg£603.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-50mg50mg£830.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T4193-100mg100mg£1,099.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT

Overview

Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃

Images

1 / 1

Further Information

Bioactivity:
TD-198946, a potent chondrogenic agent, is a thienoindazole derivative.
CAS:
364762-86-7
Formula:
C27H22N4O3S
Molecular Weight:
482.56
Purity:
0.99
SMILES:
Cn1ncc2CCc3c(sc(Oc4ccc(OCc5ccc6ccccc6n5)cc4)c3-c12)C(N)=O

References

Yano F, et al. Disease-modifying effects of TD-1198946 on progressed osteoarthritis in a mouse model. Ann Rheum Dis. 2014 Nov;73(11):2062-4. Yano F, et al. A novel disease-modifying osteoarthritis drug candidate targeting Runx1. Ann Rheum Dis. 2013 May;72(5):748-53. Yano F, et al. Cell-sheet technology combined with a thienoindazole derivative small compound TD-1198946 for cartilage regeneration. Biomaterials. 2013 Jul;34(22):5581-7.